全文获取类型
收费全文 | 21199篇 |
免费 | 1116篇 |
国内免费 | 205篇 |
专业分类
耳鼻咽喉 | 171篇 |
儿科学 | 403篇 |
妇产科学 | 179篇 |
基础医学 | 2494篇 |
口腔科学 | 413篇 |
临床医学 | 1249篇 |
内科学 | 6460篇 |
皮肤病学 | 435篇 |
神经病学 | 1311篇 |
特种医学 | 821篇 |
外科学 | 3499篇 |
综合类 | 78篇 |
一般理论 | 3篇 |
预防医学 | 560篇 |
眼科学 | 488篇 |
药学 | 1278篇 |
中国医学 | 51篇 |
肿瘤学 | 2627篇 |
出版年
2023年 | 157篇 |
2022年 | 287篇 |
2021年 | 608篇 |
2020年 | 348篇 |
2019年 | 461篇 |
2018年 | 505篇 |
2017年 | 407篇 |
2016年 | 502篇 |
2015年 | 526篇 |
2014年 | 692篇 |
2013年 | 830篇 |
2012年 | 1359篇 |
2011年 | 1568篇 |
2010年 | 889篇 |
2009年 | 693篇 |
2008年 | 1166篇 |
2007年 | 1372篇 |
2006年 | 1314篇 |
2005年 | 1275篇 |
2004年 | 1178篇 |
2003年 | 1080篇 |
2002年 | 1104篇 |
2001年 | 346篇 |
2000年 | 311篇 |
1999年 | 310篇 |
1998年 | 269篇 |
1997年 | 230篇 |
1996年 | 199篇 |
1995年 | 162篇 |
1994年 | 134篇 |
1993年 | 129篇 |
1992年 | 185篇 |
1991年 | 173篇 |
1990年 | 182篇 |
1989年 | 187篇 |
1988年 | 164篇 |
1987年 | 155篇 |
1986年 | 159篇 |
1985年 | 143篇 |
1984年 | 90篇 |
1983年 | 81篇 |
1982年 | 46篇 |
1981年 | 42篇 |
1980年 | 41篇 |
1979年 | 48篇 |
1978年 | 36篇 |
1977年 | 35篇 |
1975年 | 32篇 |
1974年 | 40篇 |
1968年 | 30篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
971.
Tomoyuki Akiyama Masahiko Inamori Hiroshi Iida Hiroki Endo Kunihiro Hosono Yasunari Sakamoto Koji Fujita Masato Yoneda Hirokazu Takahashi Tomoko Koide Chikako Tokoro Ayumu Goto Yasunobu Abe Takeshi Shimamura Noritoshi Kobayashi Kensuke Kubota Satoru Saito Atsushi Nakajima 《World journal of gastroenterology : WJG》2010,16(4)
AIM:To test the hypothesis that the shape and length of Barrett‘s epithelium are associated with prevalence of erosive esophagitis.METHODS:A total study population comprised 869 patients who underwent endoscopy during a health checkup at our hospital.The presence and extent of Barrett‘s epithelium were diagnosed based on the Prague C & M Criteria.We originally classified cases of Barrett‘s epithelium into two types based on its shape,namely,flamelike and lotus-like Barrett‘s epithelium,and into two groups b... 相似文献
972.
Kentaro Jujo Hiromichi Hamada Atsushi Iwakura Tina Thorne Haruki Sekiguchi Trevor Clarke Aiko Ito Sol Misener Toshikazu Tanaka Ekaterina Klyachko Koichi Kobayashi J?rn Tongers Jér?me Roncalli Yukio Tsurumi Nobuhisa Hagiwara Douglas W. Losordo 《Proceedings of the National Academy of Sciences of the United States of America》2010,107(24):11008-11013
We hypothesized that a small molecule CXCR4 antagonist, AMD3100 (AMD), could augment the mobilization of bone marrow (BM)-derived endothelial progenitor cells (EPCs), thereby enhancing neovascularization and functional recovery after myocardial infarction. Single-dose AMD injection administered after the onset of myocardial infarction increased circulating EPC counts and myocardial vascularity, reduced fibrosis, and improved cardiac function and survival. In mice transplanted with traceable BM cells, AMD increased BM-derived cell incorporation in the ischemic border zone. In contrast, continuous infusion of AMD, although increasing EPCs in the circulation, worsened outcome by blocking EPC incorporation. In addition to its effects as a CXCR4 antagonist, AMD also up-regulated VEGF and matrix metalloproteinase 9 (MMP-9) expression, and the benefits of AMD were not observed in the absence of MMP-9 expression in the BM. These findings suggest that AMD3100 preserves cardiac function after myocardial infarction by enhancing BM-EPC–mediated neovascularization, and that these benefits require MMP-9 expression in the BM, but not in the ischemic region. Our results indicate that AMD3100 could be a potentially useful therapy for the treatment of myocardial infarction. 相似文献
973.
Arita K Kondo T Sugita J Shigematsu A Shiratori S Wakasa K Yasumoto A Ibata M Shono Y Kikuchi M Goto H Takeda Y Takahata M Kato N Nishio M Ota S Tanaka J Imamura M 《International journal of hematology》2011,94(3):291-295
The prognosis of patients receiving allogeneic hematopoietic stem cell transplantation (HSCT) for refractory acute lymphoblastic leukemia (ALL) is very poor. To improve survival rates, we attempted to intensify the conditioning regimen with daunorubicin, vincristine, prednisolone, medium-dose etoposide, cyclophosphamide, and total body irradiation (DNR/VCR/PSL plus medium-dose VP/CY/TBI). Four patients in relapse or induction failure of B-precursor ALL without other complications underwent allogeneic HSCT. Initially, chemotherapy comprising DNR 60 mg/m(2) for 3 days, VCR 1.4 mg/m(2) for 1 day, and PSL 60 mg/m(2) for 3 days was administered, which was followed by medium-dose VP/CY/TBI; some modifications were made for individual patients. All patients achieved engraftment and complete remission after HSCT. Regimen-related toxicities were tolerable and no patient died within 100 days. Two patients were alive without disease on days 563 and 1,055. The third patient relapsed on day 951, while the fourth died on day 179 without disease. Our results indicate that intensified myeloablative HSCT should be considered for patients with refractory ALL. 相似文献
974.
Satoshi Shakado Yuko Akehi Kaoru Yotsumoto Atsushi Fukunaga Shizuka Kuno Takashi Tanaka Kunitoshi Sakurai Hideyuki Iwashita Shuichi Ueda Genryu Hirano Keiji Yokoyama Daisuke Morihara Shinya Nishizawa Masaharu Sakamoto Akira Anan Yasuaki Takeyama Makoto Irie Kaoru Iwata Tetsuro Sohda Shotaro Sakisaka 《Clinical journal of gastroenterology》2011,4(4):255-261
Hepatitis C-associated osteosclerosis (HCAO) is a rare disorder characterized by a marked increase in skeletal mass in patients who are infected with hepatitis C virus (HCV). The clinical presentation is an acquired deep bone pain with increased serum alkaline phosphatase (ALP) activity. We present a case of a patient with HCAO who was treated with antiviral therapy. A 42-year-old Japanese man presented with severe, stabbing pain in his lower limbs. He was diagnosed with hepatitis C secondary to intravenous drug use 20 years earlier. Serum biochemical studies revealed markedly elevated ALP activity and osteocalcin levels. Skeletal radiographs showed diffuse bony sclerosis with marked cortical thickening in the long bones. The bony findings and clinical symptoms were attributed to HCAO. The HCV RNA viral load was high and the genotype was 2a. The patient was treated with peginterferon alfa-2b and ribavirin for 24 weeks. After 24 weeks of the combination therapy, the patient had a sustained virological response and clinical remission of bone pain and a decrease in the level of serum ALP. In conclusion, HCAO was improved by the combination therapy of peginterferon alfa-2b and ribavirin when the patient achieved sustained virological response. It was confirmed that HCAO was one of the extrahepatic manifestations of HCV. 相似文献
975.
Yoshiko Tomita Emma Hansson Florent Mazuir Gustaf J Wellhagen Qing Xi Ooi Enrica Mezzalana Atsushi Kitamura Daisuke Nemoto Sbastien Bolze 《CTS Clinical and Translational Science》2022,15(4):1014
Imeglimin is an orally administered first‐in‐class drug to treat type 2 diabetes mellitus (T2DM) and is mainly excreted unchanged by the kidneys. The present study aimed to define the pharmacokinetic (PK) characteristics of imeglimin using population PK analysis and to determine the optimal dosing regimen for Japanese patients with T2DM and chronic kidney disease (CKD). Imeglimin plasma concentrations in Japanese and Western healthy volunteers, and patients with T2DM, including patients with mild to severe CKD with an estimated glomerular filtration rate (eGFR) greater than 14 ml/min/1.73 m2 were included in a population PK analysis. PK simulations were conducted using a population PK model, and the area under concentration‐time curve (AUC) was extrapolated with power regression analysis to lower eGFR. The influence of eGFR, weight, and age on apparent clearance and of dose on relative bioavailability were quantified by population PK analysis. Simulations and extrapolation revealed that the recommended dosing regimen based on the AUC was 500 mg twice daily (b.i.d.) for patients with eGFR 15–45 ml/min/1.73 m2, and 500 mg with a longer dosing interval was suggested for those with eGFR less than 15. Simulations revealed that differences in plasma AUCs between Japanese and Western patients at the same dose were mainly driven by a difference in the eGFR and that the plasma AUC after 1000 and 1500 mg b.i.d. in Japanese and Western patients, respectively, was comparable in the phase IIb studies. These results indicate suitable dosages of imeglimin in the clinical setting of T2DM with renal impairment. Study Highlights
- WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC?
- WHAT QUESTION DID THIS STUDY ADDRESS?
- WHAT DOES THIS STUDY ADD TO OUR KNOWLEDGE?
- HOW MIGHT THIS CHANGE CLINICAL PHARMACOLOGY OR TRANSLATIONAL SCIENCE?
976.
Shunji Fujimori Ryohei Hamakubo Aitoshi Hoshimoto Takayoshi Nishimoto Jun Omori Naohiko Akimoto Shu Tanaka Atsushi Tatsuguchi Katsuhiko Iwakiri 《World journal of gastroenterology : WJG》2022,28(39):5658-5665
The frequency of primary small intestinal adenocarcinoma is increasing but is still low. Its frequency is approximately 3% of that of colorectal adenocarcinoma. Considering that the small intestine occupies 90% of the surface area of the gastrointestinal tract, small intestinal adenocarcinoma is very rare. The main site of small intestinal adenocarcinoma is the proximal small intestine. Based on this characteristic, dietary animal proteins/lipids and bile concentrations are implicated and reported to be involved in carcinogenesis. Since most nutrients are absorbed in the proximal small intestine, the effect of absorbable intestinal content is a suitable explanation for why small intestinal adenocarcinoma is more common in the proximal small intestine. The proportion of aerobic bacteria is high in the proximal small intestine, but the absolute number of bacteria is low. In addition, the length and density of villi are greater in the proximal small intestine. However, the involvement of villi is considered to be low because the number of small intestinal adenocarcinomas is much smaller than that of colorectal adenocarcinomas. On the other hand, the reason for the low incidence of small intestinal adenocarcinoma in the distal small intestine may be that immune organs reside there. Genetic and disease factors increase the likelihood of small intestinal adenocarcinoma. In carcinogenesis experiments in which the positions of the small and large intestines were exchanged, tumors still occurred in the large intestinal mucosa more often. In other words, the influence of the intestinal contents is small, and there is a large difference in epithelial properties between the small intestine and the large intestine. In conclusion, small intestinal adenocarcinoma is rare compared to large intestinal adenocarcinoma due to the nature of the epithelium. It is reasonable to assume that diet is a trigger for small intestinal adenocarcinoma. 相似文献
977.
Shinji Ueno Yusuke Seino Shihomi Hidaka Ryuya Maekawa Yuko Takano Michiyo Yamamoto Mika Hori Kana Yokota Atsushi Masuda Tatsuhito Himeno Shin Tsunekawa Hideki Kamiya Jiro Nakamura Hitoshi Kuwata Haruki Fujisawa Megumi Shibata Takeshi Takayanagi Yoshihisa Sugimura Daisuke Yabe Yoshitaka Hayashi Atsushi Suzuki 《Nutrients》2022,14(5)
(1) Background: Protein stimulates the secretion of glucagon (GCG), which can affect glucose metabolism. This study aimed to analyze the metabolic effect of a high-protein diet (HPD) in the presence or absence of proglucagon-derived peptides, including GCG and GLP-1. (2) Methods: The response to HPD feeding for 7 days was analyzed in mice deficient in proglucagon-derived peptides (GCGKO). (3) Results: In both control and GCGKO mice, food intake and body weight decreased with HPD and intestinal expression of Pepck increased. HPD also decreased plasma FGF21 levels, regardless of the presence of proglucagon-derived peptides. In control mice, HPD increased the hepatic expression of enzymes involved in amino acid metabolism without the elevation of plasma amino acid levels, except branched-chain amino acids. On the other hand, HPD-induced changes in the hepatic gene expression were attenuated in GCGKO mice, resulting in marked hyperaminoacidemia with lower blood glucose levels; the plasma concentration of glutamine exceeded that of glucose in HPD-fed GCGKO mice. (4) Conclusions: Increased plasma amino acid levels are a common feature in animal models with blocked GCG activity, and our results underscore that GCG plays essential roles in the homeostasis of amino acid metabolism in response to altered protein intake. 相似文献
978.
979.
980.
Successful multitarget therapy using prednisolone,mizoribine and tacrolimus for Henoch–Schönlein purpura nephritis in children 下载免费PDF全文